Bayer Wins First Global Approval for Stroke Prevention Drug in China
Bayer said China authorized the launch of its drug to prevent recurrent stroke, marking the first global approval for a new class of medicines.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bayer said China authorized the launch of its drug to prevent recurrent stroke, marking the first global approval for a new class of medicines.